FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LIRALTAGENE AUTOLEUCEL
异名/同义词AUTOLOGOUS CD4+/CD8+ ENRICHED T LYMPHOCYTES DERIVED FROM LEUKAPHERESIS MATERIAL, TRANSDUCED WITH A NON-REPLICATING MURINE STEM CELL VIRUS (MSCV)-DERIVED GAMMA RETROVIRAL VECTOR, ENCODING CODON-OPTIMISED FOLLICLE-STIMULATING HORMONE (FSH) (SUBUNITS FSH.BETA. AND CG.ALPHA., LINKED BY A GLYCINE/SERINE SPACER), PRECEDED BY THE FSH.BETA. SIGNAL PEPTIDE, AND FUSED TO A CD8.ALPHA. HINGE AND TRANSMEMBRANE DOMAIN, A 4-1BB CO-STIMULATORY DOMAIN AND A CD3.ZETA. SIGNALLING DOMAIN, UNDER CONTROL OF THE MOLONEY MURINE LEUKEMIA VIRUS (MMLV) LTR PROMOTER. THE VECTOR ALSO HAS LONG TERMINAL REPEATS (LTRS) DERIVED FROM MSCV AND AN EXTENDED PACKAGING SIGNAL (.PSI.+) DERIVED FROM MMLV AND HAS A SPLICE ACCEPTOR SEQUENCE IMMEDIATELY UPSTREAM OF THE START CODON. A KOZAK SEQUENCE PRECEDES THE TRANSGENE.
LIRALTAGENE AUTOLEUCEL
LIRALTAGENE AUTOLEUCEL [INN]
CAS登记号
物质唯一标识(Unique Ingredient Identifier)6NEK9A2UZ5
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System